ARCHIVES

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

This article is from The Cancer Letter archive.

Vol. 40 No. 05 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

NCI RFAs Available

May 5, 2000

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986

Tobacco Linked To 63 Percent Of Cancer Deaths In Black Men

July 29, 2005